Synlogic Discontinues Development of SYNB1020 to Treat Hyperammonemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. MU
6. FDX
7. IBM
8. PRIM
9. PFE
10. AWK

Go back to Synlogic Discontinues Development of SYNB1020 to Treat Hyperammonemia
(NASDAQ: SYBX) Delayed: 0.56 --0 (-0%)
Previous Close $0.56    52 Week High $ 
Open $0.56    52 Week Low $ 
Day High $0.56    P/E N/A 
Day Low $0.56    EPS $ 
Volume 5,006